SCD Biomarker study

Inflammatory biomarkers in patients with sickle cell disease

 

This research is being conducted to characterize how inflammatory biomarkers change and fluctuate over the course of a month. We are enrolling adult men and women with a diagnosis of sickle cell disease into this study. The primary purpose of the study is to identify variations and differences between female and male patients, how those relate to pain episodes, and, for female participants, how those variations correlate to the menstrual cycle. 

If you agree to join the study, you will be asked to complete the following research procedures: 
 

• Blood draws every five days for a total of up to eight blood draws. 

• Surveys/questionnaires 

• Urine pregnancy tests for female participants only. 

• Access to medical records to obtain biographic and medical information. 
   

Your participation would last for approximately one month. 

If this is something you may be interested in learning more about, please click this link to fill out a survey to determine if you are eligible: https://redcap.link/scdbiomarkers. If you have direct questions for the study team, please call our office at 267-785-8044.

​

Principal Investigator:
Andrea Roe, MD, MPH

​

Study Coordinator:
(267) 785 - 8044

​

​